Integral Diagnostics (ASX: IDX) Share Price

IDX

$2.04▲+0.49%

$761.1MRank #385 on ASXHealthcareMedical - Diagnostics & Research

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$761.1M

Volume

1.9M

P/E Ratio

26.42

EPS

$0.024

Dividend Yield

1.47%

52-Week High

$3.07

52-Week Low

$1.905

Beta

0.107

Integral Diagnostics (ASX: IDX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $761.1M and the 385th-largest security on the ASX by market capitalisation. The IDX share price is $2.04, up 0.49% today and down 11.69% over the past 12 months. Shares have traded between $1.905 and $3.07 over the past 52 weeks. IDX trades on a price-to-earnings ratio of 26.42, above the Healthcare sector median of 14.96, and pays a trailing dividend yield of 1.47%. In its most recent reported period (ending 31 Dec 2025), Integral Diagnostics reported revenue of $393.5M and a net profit of $9.0M (2.3% margin).

Charts

$2.04

24H Range

$2.02

$2.06

52-Week Range

$1.905

$3.07

About Integral Diagnostics Limited

Integral Diagnostics Limited operates within the healthcare sector, providing essential diagnostic imaging services. These services are delivered to general practitioners, medical specialists, allied health professionals, and their patients across Australia and New Zealand. The company manages its service delivery through a network of 67 radiology clinics. Integral Diagnostics was incorporated in 2008 and maintains its primary corporate office in Melbourne, Australia.

IPO Date

20 Oct 2015

CEO

Ian Kadish

Employees

1,977

Website

integraldiagnostics.com.au

Key Financial Data

Revenue (Quarterly)	$393.5M
Net Income (Quarterly)	$9.0M
Total Assets	$1.42B
Total Debt	$841.5M
Free Cash Flow	$8.0M
Return on Equity	1.32%
Profit Margin	2.28%
Operating Margin	8.47%

IDX Frequently Asked Questions

What is the Integral Diagnostics (ASX: IDX) share price?

The IDX share price is $2.04, up 0.49% for the day, based on the latest available ASX market data.

What is Integral Diagnostics's market capitalisation?

Integral Diagnostics has a market capitalisation of $761.1M, making it the 385th-largest security listed on the ASX.

Does Integral Diagnostics pay a dividend?

Yes. IDX has a trailing dividend yield of 1.47%.

What is IDX's P/E ratio?

Integral Diagnostics trades on a trailing price-to-earnings (P/E) ratio of 26.42, based on its current share price and most recent reported earnings.

Is Integral Diagnostics profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), IDX reported revenue of $393.5M and a net profit of $9.0M.

How many IDX shares are on issue?

Integral Diagnostics has approximately 373,066,537 shares on issue, based on its market capitalisation of $761.1M and current share price.

What sector is Integral Diagnostics in?

Integral Diagnostics is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.

When did Integral Diagnostics list on the ASX?

Integral Diagnostics listed on the Australian Securities Exchange on 20 Oct 2015.

Latest News

Can Integral Diagnostics (ASX:IDX) Benefit From Australia’s Growing Healthcare Demand?

Kalkine26 May 2026

Can Integral Diagnostics (ASX:IDX) Benefit From Australia’s Growing Healthcare Demand? Kalkine

Can Integral Diagnostics Limited's (ASX:IDX) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Yahoo Finance13 Jan 2026

Can Integral Diagnostics Limited's (ASX:IDX) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price? Yahoo Finance

Macquarie predicts this ASX All Ords healthcare stock to surge past $1 billion over the next 12 months

The Motley Fool Australia3 Dec 2025

Macquarie predicts this ASX All Ords healthcare stock to surge past $1 billion over the next 12 months The Motley Fool Australia

Integral Diagnostics H1 2026 Thin 1.8% Net Margin Tests Bullish Growth Narratives

simplywall.st24 Feb 2026

Integral Diagnostics H1 2026 Thin 1.8% Net Margin Tests Bullish Growth Narratives simplywall.st

Health Check: Integral says ‘we’re stronger together’ after bumper merger result

Stockhead24 Feb 2026

Health Check: Integral says ‘we’re stronger together’ after bumper merger result Stockhead

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
4DX4DMedical Limited	$2.19B	$3.68	-3.16	0.00%	▲+1.38%
NANNanosonics Limited	$992.4M	$3.32	31.27	0.00%	–+0.00%
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
PNVPolyNovo Limited	$666.7M	$0.965	70799.02	0.00%	▼-4.46%
OCAOceania Healthcare Limited	$420.1M	$0.58	-26.28	0.00%	▲+0.87%
ACLAustralian Clinical Labs Limited	$405.4M	$2.16	23.92	3.29%	–+0.00%
MVFMonash IVF Group Limited	$266.9M	$0.685	10.00	0.00%	▲+2.24%
HLSHealius Limited	$261.4M	$0.36	-5.40	0.00%	▲+5.88%

ETFs That Hold IDX

IDX is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.29% of its portfolio.

Fund	Portfolio Weight	Fund Size
ISOiShares S&P/ASX Small Ordinaries ETF	0.29%	$134.5M
VASVanguard Australian Shares Index ETF	0.04%	$26.10B
QOZBetaShares - FTSE RAFI Australia 200 ETF	0.01%	$1.21B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.03	$2.06	$2.02	$2.04	1.5M	▲+1.49%
11 June 2026	$2.01	$2.07	$2.00	$2.01	1.3M	▼-0.74%
10 June 2026	$2.01	$2.035	$1.97	$2.025	1.3M	▲+1.76%
9 June 2026	$2.02	$2.04	$1.905	$1.99	4.7M	▼-3.86%
8 June 2026	$2.03	$2.07	$2.01	$2.07	2.3M	▲+0.73%
5 June 2026	$2.025	$2.06	$2.01	$2.055	1.8M	▲+1.73%
4 June 2026	$2.08	$2.08	$2.01	$2.02	1.2M	▼-1.22%
3 June 2026	$2.12	$2.12	$2.04	$2.045	2.8M	▼-3.54%
2 June 2026	$2.15	$2.155	$2.10	$2.12	710K	▼-2.30%
1 June 2026	$2.17	$2.215	$2.14	$2.17	815K	▲+0.46%
29 May 2026	$2.14	$2.16	$2.105	$2.16	1.6M	▲+2.61%
28 May 2026	$2.08	$2.12	$2.075	$2.105	1.9M	▲+0.96%
27 May 2026	$2.06	$2.085	$2.06	$2.085	662K	▲+0.24%
26 May 2026	$2.07	$2.10	$2.05	$2.08	3.3M	–+0.00%
25 May 2026	$2.08	$2.09	$2.05	$2.08	213K	▲+0.48%
22 May 2026	$2.04	$2.09	$2.00	$2.07	658K	▲+2.22%
21 May 2026	$2.10	$2.10	$2.01	$2.025	825K	▼-0.98%
20 May 2026	$2.09	$2.09	$2.02	$2.045	1.1M	▼-1.68%
19 May 2026	$2.12	$2.12	$2.07	$2.08	707K	▲+0.97%
18 May 2026	$2.12	$2.12	$2.05	$2.06	998K	▼-3.74%
15 May 2026	$2.17	$2.19	$2.13	$2.14	1M	▼-1.61%
14 May 2026	$2.20	$2.20	$2.16	$2.175	708K	▲+0.23%
13 May 2026	$2.21	$2.21	$2.15	$2.17	303K	–+0.00%
12 May 2026	$2.22	$2.22	$2.14	$2.17	456K	▼-2.47%
11 May 2026	$2.26	$2.26	$2.21	$2.225	558K	▼-1.77%
8 May 2026	$2.275	$2.285	$2.25	$2.265	171K	▼-1.09%
7 May 2026	$2.26	$2.32	$2.25	$2.29	430K	▲+1.55%
6 May 2026	$2.25	$2.26	$2.20	$2.255	297K	▲+1.81%
5 May 2026	$2.26	$2.26	$2.21	$2.215	376K	▼-2.64%
4 May 2026	$2.20	$2.28	$2.19	$2.275	357K	▲+2.94%

About Integral Diagnostics Limited

IPO Date

20 Oct 2015

CEO

Ian Kadish

Employees

1,977

Website

integraldiagnostics.com.au

IDX Frequently Asked Questions

What is the Integral Diagnostics (ASX: IDX) share price?

The IDX share price is $2.04, up 0.49% for the day, based on the latest available ASX market data.

What is Integral Diagnostics's market capitalisation?

Integral Diagnostics has a market capitalisation of $761.1M, making it the 385th-largest security listed on the ASX.

Does Integral Diagnostics pay a dividend?

Yes. IDX has a trailing dividend yield of 1.47%.

What is IDX's P/E ratio?

Integral Diagnostics trades on a trailing price-to-earnings (P/E) ratio of 26.42, based on its current share price and most recent reported earnings.

Is Integral Diagnostics profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), IDX reported revenue of $393.5M and a net profit of $9.0M.

How many IDX shares are on issue?

Integral Diagnostics has approximately 373,066,537 shares on issue, based on its market capitalisation of $761.1M and current share price.

What sector is Integral Diagnostics in?

Integral Diagnostics is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.

When did Integral Diagnostics list on the ASX?

Integral Diagnostics listed on the Australian Securities Exchange on 20 Oct 2015.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
4DX4DMedical Limited	$2.19B	$3.68	-3.16	0.00%	▲+1.38%
NANNanosonics Limited	$992.4M	$3.32	31.27	0.00%	–+0.00%
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
PNVPolyNovo Limited	$666.7M	$0.965	70799.02	0.00%	▼-4.46%
OCAOceania Healthcare Limited	$420.1M	$0.58	-26.28	0.00%	▲+0.87%
ACLAustralian Clinical Labs Limited	$405.4M	$2.16	23.92	3.29%	–+0.00%
MVFMonash IVF Group Limited	$266.9M	$0.685	10.00	0.00%	▲+2.24%
HLSHealius Limited	$261.4M	$0.36	-5.40	0.00%	▲+5.88%

ETFs That Hold IDX

IDX is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.29% of its portfolio.

Fund

Portfolio Weight

Fund Size

ISOiShares S&P/ASX Small Ordinaries ETF

0.29%

$134.5M

VASVanguard Australian Shares Index ETF

0.04%

$26.10B

QOZBetaShares - FTSE RAFI Australia 200 ETF

0.01%

$1.21B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.03	$2.06	$2.02	$2.04	1.5M	▲+1.49%
11 June 2026	$2.01	$2.07	$2.00	$2.01	1.3M	▼-0.74%
10 June 2026	$2.01	$2.035	$1.97	$2.025	1.3M	▲+1.76%
9 June 2026	$2.02	$2.04	$1.905	$1.99	4.7M	▼-3.86%
8 June 2026	$2.03	$2.07	$2.01	$2.07	2.3M	▲+0.73%
5 June 2026	$2.025	$2.06	$2.01	$2.055	1.8M	▲+1.73%
4 June 2026	$2.08	$2.08	$2.01	$2.02	1.2M	▼-1.22%
3 June 2026	$2.12	$2.12	$2.04	$2.045	2.8M	▼-3.54%
2 June 2026	$2.15	$2.155	$2.10	$2.12	710K	▼-2.30%
1 June 2026	$2.17	$2.215	$2.14	$2.17	815K	▲+0.46%
29 May 2026	$2.14	$2.16	$2.105	$2.16	1.6M	▲+2.61%
28 May 2026	$2.08	$2.12	$2.075	$2.105	1.9M	▲+0.96%
27 May 2026	$2.06	$2.085	$2.06	$2.085	662K	▲+0.24%
26 May 2026	$2.07	$2.10	$2.05	$2.08	3.3M	–+0.00%
25 May 2026	$2.08	$2.09	$2.05	$2.08	213K	▲+0.48%
22 May 2026	$2.04	$2.09	$2.00	$2.07	658K	▲+2.22%
21 May 2026	$2.10	$2.10	$2.01	$2.025	825K	▼-0.98%
20 May 2026	$2.09	$2.09	$2.02	$2.045	1.1M	▼-1.68%
19 May 2026	$2.12	$2.12	$2.07	$2.08	707K	▲+0.97%
18 May 2026	$2.12	$2.12	$2.05	$2.06	998K	▼-3.74%
15 May 2026	$2.17	$2.19	$2.13	$2.14	1M	▼-1.61%
14 May 2026	$2.20	$2.20	$2.16	$2.175	708K	▲+0.23%
13 May 2026	$2.21	$2.21	$2.15	$2.17	303K	–+0.00%
12 May 2026	$2.22	$2.22	$2.14	$2.17	456K	▼-2.47%
11 May 2026	$2.26	$2.26	$2.21	$2.225	558K	▼-1.77%
8 May 2026	$2.275	$2.285	$2.25	$2.265	171K	▼-1.09%
7 May 2026	$2.26	$2.32	$2.25	$2.29	430K	▲+1.55%
6 May 2026	$2.25	$2.26	$2.20	$2.255	297K	▲+1.81%
5 May 2026	$2.26	$2.26	$2.21	$2.215	376K	▼-2.64%
4 May 2026	$2.20	$2.28	$2.19	$2.275	357K	▲+2.94%